LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-11-20
Case ID: NM_000546.6_c.-136del_20261120_023503
Framework: ACMG/AMP 2015
Variant classification summary

NM_000546.6:c.-136del

TP53  · NP_000537.3:p.?  · NM_000546.6
GRCh37: chr17:7590801 CT>C  ·  GRCh38: chr17:7687483 CT>C
Gene: TP53 Transcript: NM_000546.6
Final call
VUS
PM2 supporting
All criteria require review: For research and educational purposes only.
Gene
TP53
Transcript
NM_000546.6
Protein
NP_000537.3:p.?
gnomAD AF
ClinVar
OncoKB
Interpretation summary
Generated evidence synthesis
1
VUS: PM2 (supporting) reflects absence from gnomAD v2.1 and v4.1, below the VCEP's 0.003% threshold.
Final determination: Under the ClinGen TP53 VCEP Version 2.4 point-based framework, PM2 supporting contributes 1 point, and totals from -1 through 5 are classified as VUS.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 N/A Not applicable: c.-136del is a 5′-UTR exon 1 deletion, not a VCEP-listed null or canonical splice variant, with maximum SpliceAI delta 0.004.
cspec vcep_pvs1_flowchart vcep_pvs1_splicing_worksheet spliceai
PS1 N/A Not applicable: c.-136del is a 5' untranslated-region deletion with no amino-acid change for comparison under the TP53 PS1 rule.
cspec
PS2 Not assessed Not assessed: no proband, parental-testing, or de novo observation is available to assign the VCEP's 1-, 2-3-, 4-7-, or ≥8-point PS2 strength.
cspec vcep_table_of_lfs_cancers_and_points_for_ps2_and_pp1_code_application
PS3 N/A Not applicable: c.-136del is an upstream 5' untranslated-region deletion with p.? rather than a missense or small in-frame deletion covered by the TP53 functional framework.
cspec vcep_flowchart_for_application_of_functional_rule_codes vcep_functional_worksheet
PS4 Not assessed Not assessed: no proband phenotype, LFS criteria, cancer age, or case-control counts are available to calculate the VCEP PS4 points.
cspec vcep_ps4_points_table
PM1 N/A Not applicable: c.-136del is a non-missense 5' untranslated-region deletion, outside both TP53 VCEP PM1 routes requiring missense variants.
cspec
PM2 Met Met at supporting: the variant is absent from gnomAD v2.1 and v4.1, giving observed frequency 0 below the 0.003% PM2 threshold.
cspec gnomad_v2 gnomad_v4
PM3 N/A Not applicable: the TP53 VCEP explicitly excludes PM3 for TP53/Li-Fraumeni syndrome, regardless of available phase or affected-proband observations.
cspec
PM4 N/A Not applicable: the TP53 VCEP Version 2.4 CSPEC entry explicitly marks PM4 as Not Applicable.
cspec
PM5 N/A Not applicable: c.-136del has no amino-acid residue, while TP53 PM5 requires a missense variant and a different classified missense variant at that residue.
cspec
PM6 N/A Not applicable: the TP53 VCEP explicitly designates PM6 as Not Applicable.
cspec
PP1 Not assessed Not assessed: no family genotypes or meioses are available to compare with the VCEP thresholds of 3-4, 5-6, or ≥7 cosegregating meioses.
cspec vcep_table_of_lfs_cancers_and_points_for_ps2_and_pp1_code_application
PP2 N/A Not applicable: the TP53 VCEP explicitly designates PP2 as not applicable for this framework.
cspec
PP3 N/A Not applicable: c.-136del is a 5′ UTR deletion, outside the VCEP PP3 scopes for missense, in-frame deletion, and splice variants.
cspec vcep_flowchart_for_application_of_pp3_2c_bp4_2c_and_bp7
PP4 Not assessed Not assessed: no multigene-panel blood observations or variant allele fractions are available for the VCEP PP4 thresholds.
cspec
PP5 N/A Not applicable: the TP53 VCEP expressly prohibits use of PP5 for this specification.
cspec
BA1 Not met Not met: the variant is absent from gnomAD v2.1 and v4.1, so its observed frequency is below the 0.1% BA1 threshold.
cspec gnomad_v2 gnomad_v4
BS1 Not met Not met: the variant is absent from gnomAD v2.1 and v4.1, rather than having a 0.03%–less-than-0.1% qualifying population frequency.
cspec gnomad_v2 gnomad_v4
BS2 Not assessed Not assessed: no carrier-level data identify unrelated cancer-free women aged at least 60 years from one source.
cspec gnomad_v2 gnomad_v4
BS3 N/A Not applicable: c.-136del is an upstream 5' untranslated-region deletion with p.? rather than a missense or small in-frame deletion covered by the TP53 functional framework.
cspec vcep_flowchart_for_application_of_functional_rule_codes vcep_functional_worksheet
BS4 Not assessed Not assessed: no affected family members with genotype results are available to demonstrate the VCEP-defined lack of segregation required for BS4.
cspec vcep_table_of_lfs_cancers_and_points_for_ps2_and_pp1_code_application
BP1 N/A Not applicable: the TP53 VCEP excludes BP1 because truncating variants account for only a portion of TP53 disease-causing variants.
cspec
BP2 N/A Not applicable: the TP53 VCEP marks BP2 Not applicable, so phase-confirmed trans observations cannot establish this criterion under version 2.4.
cspec
BP3 N/A Not applicable: the TP53 VCEP Version 2.4 CSPEC entry explicitly marks BP3 as Not Applicable.
cspec
BP4 N/A Not applicable: c.-136del is a 5′ UTR deletion, outside the VCEP BP4 scopes for missense, in-frame deletion, silent, and intronic variants.
cspec vcep_flowchart_for_application_of_pp3_2c_bp4_2c_and_bp7
BP5 N/A Not applicable: the TP53 VCEP marks BP5 as not applicable for this specification.
cspec
BP6 N/A Not applicable: the TP53 VCEP expressly prohibits use of BP6 for this specification.
cspec
BP7 N/A Not applicable: c.-136del is a 5′ UTR deletion, not the synonymous or intronic variant required by the VCEP BP7 rule.
cspec vcep_flowchart_for_application_of_pp3_2c_bp4_2c_and_bp7
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.